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Abstract
Background: Prediction of long-term survival in healthy adults requires recognition of features that serve as early
indicators of successful aging. The aims of this study were to identify predictors of long-term survival in older
women and to develop a multivariable model based upon longitudinal data from the Study of Osteoporotic
Fractures (SOF).
Methods: We considered only the youngest subjects (n = 4,097) enrolled in the SOF cohort (65 to 69 years of age)
and excluded older SOF subjects more likely to exhibit a “frail” phenotype. A total of 377 phenotypic measures
were screened to determine which were of most value for prediction of long-term (19-year) survival. Prognostic
capacity of individual predictors, and combinations of predictors, was evaluated using a cross-validation criterion
with prediction accuracy assessed according to time-specific AUC statistics.
Results: Visual contrast sensitivity score was among the top 5 individual predictors relative to all 377 variables
evaluated (mean AUC = 0.570). A 13-variable model with strong predictive performance was generated using a
forward search strategy (mean AUC = 0.673). Variables within this model included a measure of physical function,
smoking and diabetes status, self-reported health, contrast sensitivity, and functional status indices reflecting
cumulative number of daily living impairments (HR ≥ 0.879 or RH ≤ 1.131; P < 0.001). We evaluated this model and
show that it predicts long-term survival among subjects assigned differing causes of death (e.g., cancer,
cardiovascular disease; P < 0.01). For an average follow-up time of 20 years, output from the model was associated
with multiple outcomes among survivors, such as tests of cognitive function, geriatric depression, number of daily
living impairments and grip strength (P < 0.03).
Conclusions: The multivariate model we developed characterizes a “healthy aging” phenotype based upon an
integration of measures that together reflect multiple dimensions of an aging adult (65-69 years of age). Age-
sensitive components of this model may be of value as biomarkers in human studies that evaluate anti-aging
interventions. Our methodology could be applied to data from other longitudinal cohorts to generalize these
findings, identify additional predictors of long-term survival, and to further develop the “healthy aging” concept.
Background
Prediction of long-term survivorship and health out-
comes among older individuals depends upon the recog-
nition of factors that contribute to healthy aging.
Individuals that exhibit healthy aging patterns maintain
high quality of life into late stages of the life span, with
few daily living impairments and a near absence of age-
related disease [1,2]. On the other hand, an unhealthy
aging trajectory is associated with the onset of comorbid
diseases, diminished quality of life, and increased mor-
tality risk [1,2]. From the standpoint of geriatric care,
the ability to predict future changes in health is of great
importance, since this can improve the efficiency and
quality of care by identifying at-risk individuals, helping
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to target preventative measures most effectively [3].
Development of prognostic models can also provide
new tools for investigations into aging mechanisms. One
view, for instance, suggests that variation in aging out-
comes is attributable to different rates of aging, with
increased healthspan in some individuals due to a
reduced “biological” relative to chronological age [4-9].
If this notion is correct, quantitative characterization of
the “biological age” construct should provide a powerful
prognostic device, and statistical models optimized to
predict long-term survival should, by direct design or
not, be based upon measures that most closely track the
progression of aging [10]. This reasoning suggests that
construction of predictive models can point towards
aging biomarkers, which are essential for investigating
aging mechanisms in long-lived organisms, for which
survival is not a practical endpoint for scientific study.
In humans, progress along these lines would be of great
value, since clinical trials have been initiated or com-
pleted for evaluation of several anti-aging interventions
[11-13], but there is no consensus on which experimen-
tal measures are in fact most suitable for detection of
decelerated aging.
Healthy aging should be recognizable based upon a
well-chosen set of measurements from a broad range of
domains, which collectively reflect the multifaceted
effects of aging, and the interdependence of these effects
among organ systems [4]. Currently, however, while
multiple sets of measurements have been proposed as
indices of “frailty” in the elderly [14-22], there is no ana-
logous set of measures to define a healthy aging pheno-
type in middle-aged or otherwise healthy adults. The
absence of an objective and well-validated summary
measure of health status has placed limits on insights
derived from well-designed studies. Caloric restriction,
for example, may slow the rate of intrinsic aging in mid-
dle-aged adults, and clinical investigations have shown
that this intervention induces favorable shifts of indivi-
dual variables, including body mass index, lipid profiles,
body fat, inflammatory markers and insulin sensitivity
[23]. It is unclear, however, which of these measures are
most robustly associated with long-term survival, which
are linked to one or instead to multiple disease pro-
cesses, which provide independent versus redundant
information, and which might ultimately constitute a
combination of variables that best characterizes the
“healthy aging” concept. To some degree, measures that
best characterize “healthy aging” are likely to overlap
with those that characterize “frailty”, such that indices
that identify “frail” individuals may also serve to detect
healthy aging as well [24]. At the same time, however,
some pre-frail and apparently healthy adults may not yet
exhibit age-related disease traits and the advanced defi-
cit accumulation to which many frailty measures are
particularly sensitive. Potentially, therefore, standard
measures of frailty may not provide optimal tools for
characterization of “healthy aging” in younger cohorts
that exclude the oldest old. A well-known frailty index,
for example, did not include a measure that directly
relates to individual smoking or diabetes status [16], but
these are certainly key factors underlying aging trajec-
tory and long-term survivorship.
Measures that best characterize “frailty” have often
been validated based on their ability to predict survival
with respect to heterogeneous populations that include
healthy younger subjects in combination with frailer
older subjects [16,21,22]. In the study of Fried et al.
[16], for example, a frailty index was validated based
upon its ability to predict short-term (8-year) survival
among subjects that varied between 65 and 101 years of
age. For characterization of healthy aging, we suggest
that greater emphasis be placed on prediction of more
long-term survival outcomes with respect to reasonably
healthy cohorts in which few subjects suffer from
advanced age-related disease [4,25]. Given this criteria,
there are numerous variables that, based upon prior epi-
demiological studies, might conceivably be included
within a “healthy aging” index. Simple body composition
measures, such as body mass index and waist circumfer-
ence, are easily obtained during a clinical interview, and
are widely used as informal indicators of mortality risk
from cardiovascular disease and cancer [26-32]. The
most useful variables, however, may in principle not be
directly linked to any single disease process, but might
instead reflect a subject’s overall health and fitness
[33-35]. These measures, which have generally not been
evaluated in human studies of anti-aging interventions,
include tests of mental function [36], hand-grip strength
[37], visual acuity [38], walking ability [39], or indices
based upon total accumulation of “deficits” or health
disorders [19,34,35,40-43]. A wide range of measures at
cellular and physiological levels, such as blood glucose
[44], telomere length [45], inflammation markers [46],
and bone turnover rates [47], could potentially provide
further information regarding future health status of
subjects. Moreover, in humans, feedback generated from
standardized questionnaires can provide inexpensive,
easily obtained, and potentially valuable prognostic data
for prediction of both lifespan and healthspan [48,49].
Given all the variables previously shown to predict sur-
vival in certain cohorts, a key challenge is to establish
the relative value of individual variables, and to isolate
those that can be used to form a parsimonious predic-
tive model. For this purpose, data mining methods
applied to large datasets are especially useful [10], and
such approaches can be used to derive evidence-based
indices that will ultimately bolster efficiency in both
clinical and research settings [50-54].
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The goal of this study was to identify variables useful
for prediction of long-term survival within a cohort of
women between the ages of 65 and 69, and to develop a
multivariate index of healthy aging that can potentially
provide a clinical and research tool. We analyze data
from 4,097 women (65 to 69 years of age) enrolled
between 1986 and 1988 in the Study of Osteoporotic
Fractures (SOF) and followed prospectively over an
average of 16.1 years for mortality. This cohort was
well-suited for our investigation, since most subjects
were healthy at baseline examinations, with low inci-
dence of advanced age-related disease. Additionally, all
subjects in the SOF study had been evaluated with
respect to hundreds of variables relating to body compo-
sition, visual acuity, physical performance and function,
demographic measures, mental health, lifestyle practices,
current and previous medication use, and family history.
The data we consider thus represent a valuable resource
for establishing the relative prognostic value of numer-
ous phenotypic traits, and for identifying indices of vari-
ables that best predict long-term survival, which may
lead to standardized criteria to characterize the pheno-
type that precedes successful aging.
Methods
Study Population
The Study of Osteoporotic Fractures (SOF) is a prospec-
tive cohort study of community-dwelling Caucasian
women over the age of 65. Participants were recruited
between September 1986 and October 1988 based upon
community-based listings (e.g., health plan membership
lists, voter registration lists, and Department of Motor
Vehicle tapes) from four separate regions in the United
States (The Kaiser Foundation Research Institute and
Center for Health Research, Portland, Oregon; The Epi-
demiology Clinical Research Center at the University of
Minnesota, Minneapolis, Minnesota; Monongahela Val-
ley Clinic of the University of Pittsburgh, Monessen,
Pennsylvania; and The University of Maryland Osteo-
porosis Clinic, Baltimore, Maryland). The SOF was ori-
ginally designed to identify risk factors for osteoporotic
fractures, and therefore excluded women unable to walk
without assistance and women with bilateral hip repla-
cements. Black women were also excluded from the
baseline exam due to their low incidence of hip fracture.
All subjects provided written consent at entry into the
study and at each clinical examination. The protocol
and consent form were approved by the institutional
review boards (IRB) at all participating institutions (i.e.,
Kaiser Permanente Northwest IRB; University of Pitts-
burgh IRB; University of Minnesota IRB; California Paci-
fic Medical Center IRB; University of Maryland, School
of Medicine Human Research Protections Office;
University of California, San Francisco Committee on
Human Research).
The complete SOF cohort included 9704 women
between the ages of 65 and 89, with a median age of 70
years (Additional File 1). Since the main purpose of our
analysis was to identify factors associated with healthy
aging and long-term survivorship, it was desirable to
exclude older subjects, since this group was much more
likely to be short-lived and more likely to exhibit symp-
toms associated with frailty [16]. Our analysis therefore
focuses on the 4097 SOF participants less than 70 years
of age at the baseline examination (Additional File 1).
Mortality assessments were completed in this cohort at
4-month intervals by mail or phone contact of partici-
pants (or family member proxies). For each death, an
official death certificate was obtained and, when possi-
ble, a hospital discharge summary as well. This informa-
tion was used by one or more epidemiologists to assign
cause of death, in accordance with International Classi-
fication of Disease, Ninth Revision, Clinical Modification
(ICD9) codes. It should be noted that, in general, some
level of classification error is likely in the assignment of
ICD9 codes, particularly among older individuals in
whom comorbidities are frequent. Nevertheless, athero-
sclerosis was the most frequently assigned cause of
death, and was assigned in 467 of 1523 (30.7%) docu-
mented cases (ICD9 = 425; ICD9 = 429.2; 440 ≤ ICD9 <
445; ICD9 = 428; 401 ≤ ICD9 < 405; 410 ≤ ICD9 < 415;
ICD9 = 798; 430 ≤ ICD9 < 439. Cancer deaths were
also common, and cancer was assigned as the cause in
426 of 1523 (27.8%) of documented deaths (140 ≤ ICD9
< 240). More than one-third (38.5%) of all deaths, how-
ever, were attributable to neither to atherosclerosis nor
cancer (586 of 1523 deaths). There were 25 deaths due
to injury and poisoning (ICD9 > = 800) and an addi-
tional 19 deaths due to other external causes of injury
(ICD9 E800-E990), and in these cases, the survival times
of subjects were right-censored (Additional File 1).
Predictor Variables and Data Pre-processing
After recruitment of the SOF cohort, study participants
have periodically returned to clinical centers for as
many as nine visits. In our analyses, however, we have
utilized only baseline variable measurements recorded in
the first visit of each SOF participant (occurring
between September 1986 and October 1988). All vari-
ables included in our analysis, therefore, are obtainable
during a single clinical examination and interview.
These variables can roughly be categorized as anthropo-
morphic (e.g., height), demographic (e.g., age and race),
blood pressure and pulse measures, cognitive function
(i.e., short mini mental status exam), family history,
female history (e.g., prior pregnancies, hysterectomy),
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physical function and performance (e.g., number of sec-
onds to complete 5 stands), medical history, medication
inventory, lifestyle survey (e.g., caffeine use) and evalua-
tion of vision (e.g., contrast sensitivity scores). Alto-
gether, the complete dataset included measurements of
465 variables on the 4097 subjects. We screened these
variables, and excluded from further analysis those with
more than 5% missing values. Following this pre-proces-
sing, there remained 300 variables (146 continuous, 28
ordinal and 126 categorical) upon which further analyses
were based. We applied Grubb’s test to each continuous
variable to check for the presence of outliers [55], and
log-transformed 77 continuous variables for which there
was strong evidence indicating that at least one outlying
observation was present (Grubb’s test; P < 10-3). All
categorical variables with n = 2 classes were coded as a
single 0-1 indicator variable. For categorical variables
with n > 2 classes, we recoded the variable as a set n of
0-1 indicator variables, with a single 0-1 indicator vari-
able representing each of the n classes. We do not use
n - 1 indicator variables in such cases, because prior to
variable selection, it was uncertain which indicators
would be selected in a final model, and it was expected
that our variable selection strategy would ultimately
identify an appropriate (and non-redundant) subset of
the n indicators for any categorical variable with n > 2
classes. This recoding of categorical variables yielded a
total of 203 categorical variables (each with 0-1 coding).
The complete analysis, therefore, was based upon a total
of 377 variables (146 continuous, 28 ordinal and 203
categorical). Further pre-processing of variables to elimi-
nate those highly correlated with other variables was
unnecessary at this stage, since this would be accom-
plished as part of model-building procedures. A com-
plete list of the 377 variables, along with 88 excluded
from the analysis, is provided as supplementary data
(see Additional File 2).
All variables included in the analysis contained fewer
than 5% missing data, and most variables included
much less than 5% missing data. Among all variables we
considered, missing values accounted for, on average,
only 0.40% of data entries. For these missing data, it was
not feasible to perform multiple imputations, given that
our analyses were computationally expensive (see
below). We therefore employed a k-nearest-neighbor
imputation approach [56], in which missing values were
replaced based upon the k = 20 nearest neighbors of a
given subject for which data was missing. The nearest
neighbors of each subject were identified based upon
the Euclidean distance across all variables. These vari-
ables included both continuous and categorical variables,
of which the Euclidean distance is meaningful only for
the former. For the purpose of nearest-neighbor compu-
tations, therefore, categorical variables were expressed as
8 standard coordinates obtained by multiple correspon-
dence analysis (with retention of 70% of the variance
associated with the entire set of 126 categorical vari-
ables). Once nearest neighbors were identified for a sub-
ject with missing data, we imputed missing data using
the average value among the k = 20 neighbors for con-
tinuous variables, the median value among the k = 20
neighbors for ordinal variables, and the modal value
among the k = 20 neighbors for categorical variables.
Statistical Assessment of Prognostic Value
One criterion for evaluating an index for healthy aging
is that the index should discriminate among subjects
based upon their observed survival times. For an index
generated from a Cox regression model, this output cor-
responds to a “risk score” (i.e., linear predictor), which
is proportional to the predicted mortality risk of a sub-
ject relative to all other subjects. This risk score is a
useful diagnostic index if subjects assigned high scores
tend to be short-lived, and if subjects assigned low
scores are usually long-lived. Along these lines, we eval-
uated predictive capacity of models based upon a cross-
validation criterion, in which a model is first constructed
using one set of subjects (i.e., a training set), and then
used to generate risk scores for a distinct set of subjects
(i.e., a testing set). The predictive capacity of the model
is measured according to how well risk scores discrimi-
nate among short and long-lived subjects within the
testing set. In our analyses, training data consisted of
randomly selected sets of 3687 subjects (90% of cohort),
while testing data consisted of the remaining 410 sub-
jects (10% of cohort). Prognostic capacity is measured
according to a concordance index (based on time-speci-
fic area under the curve (AUC) statistics; see below),
which measures the degree to which high risk scores are
assigned to short-lived subjects, and the degree to which
low scores are assigned to long-lived subjects. For a
given model, this process is repeated 10,000 times, and
the average concordance score among all simulation
trials is computed. This cross-validation approach, invol-
ving random splitting of subjects into “training” and
“testing” sets, provides a good indication of how well
the model characterizes meaningful patterns in the data
that are useful for prediction, rather than random noise
[57].
Correspondence between model-generated risk scores
and observed mortality patterns was evaluated based
upon the time-specific receiver operating characteristic
(ROC) curve approach and definitions of incident sensi-
tivity and dynamic specificity proposed by Heagerty and
Zheng [58]. This evaluation method permitted calcula-
tion of a global concordance index (C), measuring over-
all correspondence between risk scores and observed
mortality patterns, as well as time-specific metrics
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interpreted as ROC curve statistics, which provided a
useful indication of the short versus long-term prognos-
tic ability of a given model. For any survival time t, the
framework proposed by Heagerty and Zheng [58] pro-
vides a measure of how well a risk score distinguishes
at-risk subjects that die at time t from at-risk subjects
that survive beyond time t. This is done by constructing
time-specific ROC curves based upon estimates of inci-
dent sensitivity and dynamic specificity. Such a curve is
generated from a risk score marker (M), by choosing
different M threshold values (c) for predicting death,
leading to a series of sensitivity and specificity estimates
with respect to a given survival time t [58].
Sensitivity c t P M c T ti i,( ) = > =( )
Specificity c t P M c T ti i,( ) = ≤ >( )
The estimated (incident) sensitivity rate forms the ver-
tical axis of the time-specific ROC curve and reflects the
ability of risk scores to accurately identify subjects that
die at time t (i.e., true-positive identification rate). The
estimated (dynamic) specificity rate is used to calculate
false-positive rates, which forms the horizontal axis of
the time-specific ROC curve, reflecting the degree to
which high risk scores are incorrectly assigned to sub-
jects living beyond time t (i.e., 1 - Specificity).
Time-specific ROC curves were used to calculate area
under the curve statistics (i.e., AUC(t)), which provided
intuitive and useful summary measures of prognostic
capacity, with respect to certain survival times. The
interpretation of AUC values is consistent with those
generated in other contexts, with possible values ranging
between 0 and 1, and values greater than 0.50 indicative
of model output that is more useful than randomly gen-
erated risk scores. The value of AUC(t) can also be
interpreted in probabilistic terms. For two subjects with
risk scores Mj and Mk, the value of AUC(t) represents
the probability that Mj is larger than Mk, given that sub-
ject j has a survival time of t and subject k has a longer
survival time [58].
AUC t P M M( ) = >( )= j k j kT t T t> ,
The value of AUC(t) provides an indication of model
discrimination ability at a given survival time. A global
concordance measure (C) is obtained by integrating
AUC(t) values with respect to t, providing an “averaged”
value of AUC(t) that reflects overall discrimination abil-
ity across all survival times [58]. This concordance
index is interpreted as the probability that the model
can, for any two subjects chosen at random, correctly
identify which subject was the first to die [58].
C P M M T Tk j= j k> <( )
Values of AUC(t) and C are used in our analyses to
evaluate the ability of models, developed on a randomly
selected training set, to discriminate among the survival
outcomes of subjects within a testing data set. In our
analyses, data are randomly split 10,000 times into train-
ing and testing sets, and values of AUC(t) and C are
estimated with each iteration. Discrimination ability of
models over all iterations is measured by averaging
values of AUC(t) and C across all 10,000 simulations.
Results
Our analysis is based upon the youngest fraction of the
SOF cohort, consisting of 4097 Caucasian women
between 65 and 69 years of age (Additional File 1). Fol-
lowing baseline interviews and clinical examinations
(September 1986 and October 1988), most women sur-
vived during as many as 20 years of follow-up, with 90%
surviving at least 9.3 years or more, 80% surviving 13.7
years, 70% surviving 16.8 years, and 60% surviving 20.0
years (Kaplan-Meier estimates). At baseline, 3451 of the
4097 subjects (84.2%) indicated that, compared to others
of the same age, their health was either “excellent” or
“good”, suggesting that most were in moderately good
health at the beginning of the study. We evaluated 377
predictor variables generated from information collected
at the baseline evaluation, and found that many of these
variables were significantly associated with survival. We
first analyzed each variable individually by fitting a uni-
variate Cox PH model. Most variables (213/377) were
significantly associated with survival (P < 0.05), and for
38 variables, p-values were not distinguishable from zero.
We considered whether this large number of significant
results was due to correlations between predictors and
certain variables expected to have strong associations
with survival, such as baseline age, smoking history (i.e.,
whether a subject had smoked at least 100 cigarettes in
her lifetime), or whether a subject had ever been told by
a doctor that she was diabetic (Figure 1). This was not
the case, however, and we found that 214 variables were
significant after adjusting for patient age, 212 variables
were significant after adjusting for both age and smoking
history, while 201 variables were significant after adjust-
ing for age, smoking history and diabetes history (Figure
1A - 1D). We next evaluated the significance of variables
after adjusting for more direct indicators of baseline
health, such as presence of hypertension and a subject’s
self-rated health compared to others of the same age.
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After adjusting for age, smoking history, diabetes history
and hypertension, 190 of the 377 variables were signifi-
cant (Figure 1E). Likewise, a large number of variables
(168/377) were significant following adjustment for age,
smoking history, diabetes history, hypertension and self-
rated health status (Figure 1F).
Best Univariate Predictors of Long-term Survival
The prognostic capacity of each predictor was evaluated
using 10,000 cross-validation trials, with discrimination
ability of each model measured by area under the curve
(AUC) statistics generated from time-specific receiver
operating characteristic (ROC) curves [58] (see
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Figure 1 Hazard ratios. Cox PH models were used to calculate the hazard ratio associated with each of the 377 predictor variables. In each
plot, vertical lines represent 95% confidence intervals associated with log-transformed hazard ratios, with red lines indicating statistical
significance of estimated ratios (P < 0.05). Lines representing confidence intervals are ordered with respect to a variable ranking based upon the
hazard ratio point estimate obtained for each variable. In part (A), hazard ratios for each predictor variable were estimated using a univariate
model without other covariate terms. In parts (B) - (F), hazard ratios were adjusted for one or more covariates. These covariates include (B)
baseline age, (C) age and smoking history, (D) age, smoking and diabetes history, (E) age, smoking history, diabetes history and hypertension,
and (F) age, smoking history, diabetes history, hypertension and self-rated health.
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Methods). The overall quality of a model, with respect
to all survival times, was measured by a concordance
index (C), which corresponds to an average of AUC(t)
values across all survival times [58] (see Methods).
Among the 377 variables, the mean value of C across
simulations ranged from 0.500 to 0.589, and for most
variables, the average value of C was less than 0.550
(Figure 2A). The prognostic capacity of variables gener-
ally declined over time, although in most cases this
decline was slight (Figure 2B). For instance, there were
311 variables for which the mean value of AUC(1)
(AUC for survival of one year) across simulations was
larger than that of AUC(19) (corresponding to survival
to 19 years), but the opposite was true for just 66 vari-
ables (Figure 2B).
The strongest predictors appeared to fall into three
general categories: (i) physical performance measures,
(ii) contrast sensitivity scores from a visual exam, and
(iii) self-rated health assessments based on a self-admi-
nistered questionnaire (Table 1). Physical performance
measures represented the most useful predictors of sur-
vival, and included the number of step-ups a subject
was able to complete within 10 seconds (mean C =
0.589), average step length (mean C = 0.577) and walk-
ing speed (mean C = 0.573). The number of step-ups
completed in 10 seconds was, among all variables, the
strongest predictor of survival (Figure 3A). The predic-
tive value of this variable did decline over time, but this
decline was relatively small (Figure 3B), and this same
variable also had the largest value of AUC(19) among all
variables (AUC(19) = 0.587). Contrast sensitivity refers
to the ability of a subject to detect differences between
grey objects that vary in color between white and black
(measured using Pelli-Robson letter charts [59]). We
found that four related measures of contrast sensitivity
emerged as particularly useful predictors of survival
(0.564 ≤ average C ≤ 0.570) (Table 1). These measures
differ in terms of whether scores reflect both low and
high spatial frequency versus low spatial frequency, or
whether scores were normalized to the entire population
of subjects, but generally the four scores were correlated
with one another and associated with similar concor-
dance values. Lastly, the best predictors of survival
included variables derived from self-administered ques-
tionnaires completed by subjects (Table 1). These mea-
sures were a subject’s rating of their own health
compared to others (mean C = 0.579), along with com-
posite functional status indices measuring how well sub-
jects could perform daily living tasks, such as walking,
climbing up stairs, climbing down stairs, preparing
meals, doing housework, and shopping (mean C = 0.569
for both the 6 and 5-variable indices).
The variables listed in Table 1 had a relationship to
mortality that was roughly consistent among subjects
assigned different causes of death. For each measure, we
calculated hazard ratios with respect to the entire cohort
(n = 4097), or in subsets of subjects that appeared to die
of cancer (n = 426), of cardiovascular disease (n = 467),
0.50 0.54 0.58
0
5
10
15
20
25
30
35
Concordance Index
Fr
eq
ue
nc
y
(A)
0.50 0.54 0.58
0.
50
0.
52
0.
54
0.
56
0.
58
AUC (1 Year)
A
U
C
 (1
9 
Ye
ar
s)
(B)
Figure 2 Cross-validation performance of univariate models. The predictive value of each variable was evaluated based upon 10,000 cross-
validation trials. In each trial, a univariate Cox PH model was fit using a randomly chosen training dataset, and model performance was
evaluated by applying the fitted model to subjects within a randomly chosen testing dataset. The predictive value of each variable was
measured according to the average concordance index (C) among simulation trials (see Methods). The concordance index is an average of time-
specific area under the curve statistics (i.e., AUC(t)), which were calculated for t = 1, ..., 19 years of follow-up time (see Methods). Part (A) shows
the distribution of mean concordance estimates among all 377 predictor variables. In part (B), for each variable, the average value of AUC(19)
among simulation trials is plotted against the average value of AUC(1).
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or of non-accidental/non-cancer/non-cardiovascular dis-
ease (n = 586). With respect to each subset, variables
listed in Table 1 had a similar association with mortality,
although the association was in each case weaker among
subjects for which the assigned cause of death was can-
cer (Figure 4).
We considered whether the associations between
Table 1 variables and survival might be indirect, and
due primarily to correlations with, for example, smoking
or diabetes history. We thus evaluated whether hazard
ratio estimates of Table 1 variables remained significant
in bivariate Cox PH models that included a second mea-
sure of potential importance. For each Table 1 variable,
we estimated a hazard ratio in 376 separate bivariate
models, representing all possible bivariate models that
include the Table 1 variable, given the total number of
variables included in the analysis (i.e., 377 variables). For
each Table 1 variable, significance of the estimated
hazard ratio was not altered within any bivariate Cox
PH model, with only two exceptions. First, contrast sen-
sitivity measures became non-significant (P > 0.05) if
another contrast sensitivity measure was included in the
Table 1 Variables with greatest predictive value in univariate Cox PH models
Variable Mean Concordance
(C)
Number of step-ups completed in 10 seconds 0.589
Response to Question: How is your health compared to others your age? (categories: excellent, good, fair, poor, very poor) 0.579
Average step length, Usual Pace (m) 0.577
Walking speed, Usual Pace (m/s) 0.573
Contrast sensitivity score, average of high and low spatial frequencies 0.570
Contrast sensitivity score, average of low spatial frequencies 0.569
Impairments associated with daily living, index of 6 tasks 0.569
Contrast sensitivity score, average of low spatial frequencies, normalized 0.568
Impairments associated with daily living, index of 5 tasks (walking 2 or 3 blocks, climbing up 10 steps, climbing down 10
steps, preparing own means and doing housework).
0.568
Contrast sensitivity score, average of low and high spatial frequencies, normalized 0.564
The first column provides a brief description of each variable. Mean concordance refers to an average of concordance index (C) estimates calculated in each of
10,000 cross-validation simulation trials (see Methods). The 95% confidence interval associated with the mean concordance estimate for each variable is
approximately ± 0.001.
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Figure 3 Number of step-ups completed in 10 seconds. The number of step-ups completed in 10 seconds was the best single-variable
predictor of short and long-term survival (mean C = 0.589). Part (A) shows the time-specific ROC curve corresponding to 10-years of follow-up
time. Estimates of sensitivity and specificity were calculated as described in Methods and averaged among simulation trials. The dashed line
corresponds to the null expectation with an AUC value of 0.50. Part (B) plots estimated values of AUC(t) across t = 1,..., 19 years of follow-up
time. Each point represents the average value of AUC(t) among 10,000 simulation trials, and error bars indicate the standard deviation of AUC(t)
among simulations. The solid red line indicates the mean concordance index of 0.589 among simulations, and dashed red lines represent one
standard deviation above and below the mean concordance estimate.
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same model, and second, the 5- and 6-variable func-
tional status indices were non-significant if both were
included within the same model. Otherwise, each vari-
able shown in Table 1 remained significant after adjust-
ment for any of the other variables included in the
analysis, including smoking history, diabetes history and
baseline age.
Data mining strategy for building a predictive model
We next searched for favorable combinations of vari-
ables that best predicted long-term survival. Among the
377 variables, there were 377C2 = 70876 possible pair-
wise combinations of variables. For each of the 70876
combinations, we constructed bivariate Cox PH models
and evaluated their discrimination ability using the same
0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0
Hazard Ratio
No. step−ups completed
(10 Seconds)
Health compared to others
of the same age?
Average Step Length
Walking Speed
Contrast Sensitivity
Contrast Sensitivity
(Low Spatial Frequency)
Functional Status
(6−Variable Index)
Norm. Contrast Sensitivity
(Low Spatial Frequency)
Functional Status
(5−Variable Index)
Norm. Contrast Sensitivity
Figure 4 Hazard ratio estimates associated with best predictor variables. The hazard ratio was estimated using single-variable Cox PH
models for each of the best predictor variables listed in Table 1. Each point represents a hazard ratio estimate, and horizontal lines correspond
to 95% confidence intervals associated with this estimated value. Black points correspond to hazard ratios estimated using data from all n =
4097 subjects. Hazard ratios were separately estimated based upon the n = 467 cancer deaths (red points), the n = 426 cardiovascular deaths
(green points), and the n = 586 non-accidental/non-cancer/non-cardiovascular deaths (blue points). Cause-specific ratios were calculated by
treating the n deaths assigned to a specific cause as non-censored, with censoring applied to deaths assigned to any other cause.
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cross-validation procedure described above, except that
only 20 simulation trials were performed for each bivari-
ate model. We calculated the average concordance
among the 20 trials, and this revealed that the best
models generally consisted of variables that, in univari-
ate models, had been ranked among the top 50 stron-
gest predictors (Figure 5). Using these results as a rough
screen, we identified the best 200 bivariate models, and
for these top 200 models, we performed 10,000 cross-
validation simulations, and calculated the average value
of C among the 10,000 trials. This indicated that the
best 2-variable model was based upon the number of
step-ups completed by a subject in 10 seconds, in com-
bination with information related to smoking history.
Specifically, the best model included the number of
step-ups completed and an indicator variable with value
of 1 if a subject had previously smoked (average C =
0.614). The next two top models were also based upon
the number of step-ups completed, and differed only
slightly, with the second variable related to smoking
history in each case (average C = 0.613).
Forward variable selection was then used to identify a
model that incorporated a larger number of predictor
variables. In this approach, given a “best” model with
p variables, we screened all possible models with p + 1
variables that could be formed by adding a new variable
to the best p-variable model. The process was initiated
using the best bivariate model (identified above; average
C = 0.614), and iteratively repeated until the perfor-
mance of very large p-variable models had been evalu-
ated (Figure 6). At each iteration, possible models were
evaluated using 20 cross-validation simulations, and for
each possible model, the average value of C was calcu-
lated and used to determine which model had the best
performance. We found, as expected, that the generation
of larger models through addition of new predictor vari-
ables quickly reached a point of diminishing returns
(Figure 6A). The appropriate level of model complexity
(i.e., number of variables) corresponds to the “bend” in
the curve that is shown in Figure 6A. To identify this
point quantitatively, we defined a loss function equal to
the distance between the curve shown in Figure 6A and
the upper-left hand corner of the plotting region. This
criterion suggested that the forward selection strategy
should be halted after a model with 13 variables had
been generated (see Figure 6B). We thus repeated the
forward selection process, and at each iteration, alterna-
tive models were evaluated using 500 cross-validation
simulations, and the best ten models were then re-evalu-
ated at each iteration using 20,000 cross-validation
simulations. This yielded a 13-variable model with an
average concordance value of 0.673 (Figure 7).
We searched for less complex models that might have
performed equally well, by dropping each of the
13 terms one-at-a-time, and evaluating the mean con-
cordance associated with each resulting 12-variable
model. However, we were unable to identify a smaller
model that yielded a mean concordance value equal to
or greater than 0.673. Overall, based on the process
described above, the 13-variable model we identified is
likely to be a high-quality model, but our partly heuristic
variable selection process does not exclude the possibi-
lity that another of 4.05 × 1023 possible 13-variable
models might exhibit better performance. Lastly, we
note that AUC values associated with our model are
small (Figure 7) relative to some that have been
reported in the literature for prediction of survival [60].
In part, this may reflect characteristics of the cohort we
evaluated, which did not include shorter-lived older sub-
jects for which it is usually easier to generate accurate
mortality forecasts (e.g., see Figure 2B). Additionally,
AUC values reported in our study may differ from those
of some previous investigations due to differences in
overall cohort size, the set of predictor variables used to
build prognostic models, the type of cross-validation
procedure implemented (e.g., ten-fold, five-fold, leave-
one-out, etc.), or the method used to calculate AUC
values.
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Figure 5 Performance of bivariate models. For each of 377C2 =
70876 possible combinations of the 377 predictor variables, we
generated bivariate Cox PH models and evaluated the average
concordance index (C) of each model across 20 cross-validation
simulations. Colors represent the average concordance of a given
model, with respect to the ranking of the two variables contained
in a model. The variable rankings are based upon concordance
estimates generated for each variable in univariate Cox PH models
(i.e., values from Figure 2A), with low ranks assigned to variables of
greatest predictive value.
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Figure 6 Forward variable selection. The best bivariate model was based upon the number of step-ups completed by a subject in 10 seconds
and whether a subject previously smoked (average C = 0.614). Variables were iteratively added to this model to evaluate concordance values
associated with larger models. At each iteration, given a baseline model with p variables, the concordance associated with all possible models
containing p + 1 variables was evaluated (based upon 20 cross-validation simulations). The best model containing p + 1 variables was chosen as
a new baseline model and the process repeated. Points in part (A) show the mean concordance index associated with each of the models
created by this process, and upper and lower lines indicate 95% confidence limits. (B) The size of a tentative model was chosen based upon the
value of p that minimized a loss function. The point of diminishing returns with increasing p corresponds to a “knee” or leveling off point of the
curve shown in part (A). To quantitatively locate this point, the scales shown in part (A) were mapped to the interval [0,1], and a loss function
was defined as the distance between the plotted curve and the extreme upper-left corner of the coordinate system. The value of p that
minimized this loss function is denoted by the dashed vertical lines in parts (A) and (B) (i.e., p = 13 variables).
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Figure 7 Cross-validation performance of 13-variable index. The multivariate index we developed is based upon a model that includes 13
variables (see Table 2). The discrimination ability of risk scores generated from this model was evaluated based upon cross-validation methods
and time-specific ROC curve metrics (e.g., see Figure 3). In each of 10,000 simulations, risk scores were calculated as linear predictors of Cox
regression models that included the 13 variables listed in Table 2, with coefficients estimated using 3687 subjects randomly assigned to the
testing set in each simulation, and prediction accuracy evaluated based upon discrimination ability of risk scores with respect to 410 subjects
randomly assigned to the testing set in each simulation (see Methods). In part (A), the estimated time-specific ROC curve corresponding to 10-
years follow-up time is shown. The dashed line corresponds to the null expectation with an AUC value of 0.50. Part (B) plots estimated values of
AUC(t) across t = 1,..., 19 years of follow-up time. Each point represents the average value of AUC(t) among 10,000 simulation trials, and error
bars indicate the standard deviation of AUC(t) among simulations. The solid red line indicates the mean concordance index of 0.671 among
simulations, and dashed red lines represent one standard deviation above and below the mean concordance estimate.
Swindell et al. BMC Geriatrics 2010, 10:55
http://www.biomedcentral.com/1471-2318/10/55
Page 11 of 24
A 13-variable Index that Predicts Long-Term Survival in
Women 65-69 Years of Age
The composition of the 13-variable model is described
in Table 2. Collectively, the variables relate to several
dimensions of an aging adult, including a measure of
physical performance (i.e., number of step-ups com-
pleted in 10 seconds), smoking and diabetes history, age
at baseline, self-evaluation of health compared to others,
a measure of visual performance (i.e., contrast sensitiv-
ity), indicators of cardiovascular health (i.e., pulse,
hypertension/thiazide use), height change since age 25,
and variables relating to environmental factors (i.e., the
clinic attended throughout the study and marriage sta-
tus) (Table 2). Some of the identified variables are prob-
able health determinants (e.g., smoking), while others
are more likely indicators of overall health and may not
have a causal association with survival (e.g., number of
step-ups completed in 10 seconds). The estimated
hazard ratio for each of the 13 variables was statistically
significant (P < 0.01), even when adjusted for all other
variables included in the model (Table 2). Of the 13
variables, nine could be scored based upon a self-admi-
nistered questionnaire, and only four variables require
physical examination (number of step-ups completed in
10 seconds, contrast sensitivity, pulse, hypertension/thia-
zide use). For variables requiring a physical exam, we
have listed alternative measures that could be easier to
evaluate in clinical settings (Table 2). In most cases, the
use of one substitute variable did not greatly diminish
the average concordance index of the complete model
(Table 2).
The 13 variables did not include biochemical mea-
sures, but we evaluated whether risk scores generated
from the model were associated with blood serum mea-
sures obtained from a small SOF cohort during the
baseline visit (n ≤ 400 for each of 37 measures consid-
ered). We found that model risk scores were positively
associated with C-reactive protein (rs = 0.20; P = 0.013,
n = 151), chorionic gonadotropin (rs = 0.18; P = 0.026;
n = 150), and 1,25-hydroxyvitamin D (rs = 0.16; P =
0.048; n = 151), but negatively associated with 25-hydro-
xyvitamin D (rs = -0.21; P = 0.010; n = 152). In each
case, the observed correlations, though significant, were
modest in magnitude (|r| ≤ 0.21.
We evaluated whether variables included in our model
were age-sensitive and whether the prognostic value of
the model and component variables extended to older
subjects in the SOF cohort (i.e., 70 - 89 years of age;
Table 2 Multivariate index for prediction of long-term survival
Variable HR (P-Value)
Number of step-ups completed in 10 seconds1 0.832 (< 0.001)
Smoking: indicator with value 1 if subject is a current smoker 2.354 (< 0.001)
Diabetes: indicator with value 1 if a subject is not diabetic 0.443 (< 0.001)
Age at baseline examination (65 - 69 for all subjects) 1.146 (< 0.001)
Response to Question: How is your health compared to others your age? (categories: excellent, good, fair, poor, very poor) 1.205 (< 0.001)
Smoking: indicator with value 1 if subject is a past smoker 1.390 (< 0.001)
Contrast sensitivity score, average of high and low spatial frequencies2 0.879 (< 0.001)
Pulse Lying Down (beats/60 seconds)3 1.131 (< 0.001)
Hypertension: indicator with value 1 if systolic blood pressure exceeds 160, diastolic blood pressure exceeds 90, or if subject
used thiazide4
1.324 (< 0.001)
Past thiazide use: indicator variable with value 1 if the subject has previously used thiazide 1.785 (< 0.001)
Height change since the age of 25 (self-reported at baseline exam) 1.137 (< 0.001)
Participant’s clinic throughout the study: indicator with value 1 if subject has attended clinic B 1.357 (< 0.001)
Marriage: indicator with value 1 if subject was married at the time of the baseline examination 0.822 (< 0.001)
The table lists 13 variables that comprise a subset of variables that predict long-term survival as components of a Cox PH model (mean C = 0.673 ± 0.001). The
13 variables were identified through forward search (see Results and Figure 6), and are listed in the order they were introduced into the model during the
forward selection procedure (i.e., from most to least important). The second column lists the estimated hazard ratio (HR) and p-value, based upon coefficients
obtained from the 13-variable Cox PH model. For variables that require physical measurement in a clinical setting, footnotes list potential alternative variables,
along with the average concordance index of an index that includes the alternate variable rather than the variable listed in Table 2. The listed variables were
used to generate the risk scores evaluated in Figures 8, 9 and 10, where risk scores for test subjects represent the output of a 13-variable Cox model with
coefficients corresponding to measures listed in the table below.
1Alternative variables: walking speed (m/sec) (mean C = 0.671); average step length at usual pace (m) (mean C = 0.671); average of right and left hand grip
strength (kg) (mean C = 0.668); 12-variable model with variable omitted (mean C = 0.668).
2Alternative variables: indicator with value 1 if subject does not wear glasses (mean C = 0.671); Randot test of stereoacuity, 10-level test scored based upon the
highest level correct twice (mean C = 0.671); 12-variable model with variable omitted (mean C = 0.671).
3Alternative variables: pulse while standing (beats/60 seconds) (mean C = 0.672); diastolic blood pressure while standing (mm hg) (mean C = 0.671); systolic
blood pressure while standing (mean C = 0.671); 12-variable model with variable omitted (mean C = 0.671).
4Alternative variables: waist-to-hip ratio (mean C = 0.671); body mass index (mean C = 0.670); 12-variable model with variable omitted (mean C = 0.670).
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Additional Files 3 and 4). First, to evaluate the age-sen-
sitivity of variables within the model, we carried out a
cross-sectional analysis based upon all 9704 subjects
within the SOF cohort (i.e., ages 65 - 89; Additional File
3). This analysis demonstrated that certain continuous
variables within the model exhibited monotonic or near-
monotonic trends across age groups (e.g., contrast
sensitivity scores, number of step-ups completed in
10 seconds, pulse lying down, self-reported height loss
since age 25; see Additional File 3), although we note
that inferences concerning age-associated trends based
upon cross-sectional data should be treated with cau-
tion. We next used cross-validation methods to deter-
mine whether the model accurately forecasted survival
patterns among the older SOF subjects excluded from
the above analyses (i.e., subjects 70 - 89 years of age;
Additional File 4). Among older SOF subjects, the
model predicted survival patterns with greater accuracy
than expected on the basis of chance alone, with a mean
concordance estimates of 0.630 among those aged 70-74
(n = 3033), 0.616 among those aged 75-79 (n = 1538),
0.586 among those aged 80-84 (n = 765), and 0.584
among those aged 85-89 (n = 228) (see Additional File
4; each estimate based on 10,000 cross-validation simu-
lations). The progressive decline of predictive perfor-
mance among increasingly older SOF cohorts may be
attributed to the fact that the index was developed for
prediction of (long-term) survival with respect to a rela-
tively young cohort (age 65-69), and thus includes vari-
ables for which prognostic value declines with age (i.e.,
smoking and diabetes status at baseline; see Figures C
and D from Additional File 4).
Previous studies have shown that random choice of
variables can often provide high-quality models that pre-
dict short or long-term survival, suggesting that predic-
tion accuracy may in some cases not be sensitive to an
exact specification of model variables [40,61]. To evalu-
ate this possibility, we compared the performance of our
13-varible model to models formed by choosing vari-
ables randomly from the 377 variables evaluated on the
cohort we studied (Additional File 5). This showed that
random selection of variables can indeed lead to models
that perform moderately well (0.583 ≤ mean C ≤ 0.633,
depending upon how the pool of eligible variables is fil-
tered), but in each case performance was poorer and
less consistent relative to that of the 13-variable model
described in Table 2 (see Additional File 5). We note,
however, that our model includes only 13 variables, and
that exact variable specification is likely to be less
important for larger models that include more variables
[62]. Lastly, we compared performance of our 13-vari-
able model to that of models in which an index quanti-
fying accumulation of many deficits served as the
predictor variable [22] (Additional File 6). This analysis
showed that a deficit index generated survival forecasts
more accurate than expected on the basis of chance
alone (0.584 < mean C < 0.630) (Additional File 6, Fig-
ures C - F). Among the youngest SOF subjects (age 65-
69), our 13-variable index outperformed the deficit
index (mean C of 0.673 versus 0.617), but this advantage
progressively declined as we examined increasingly older
SOF cohorts (Additional File 6, Figures C - F).
Evaluation of the Index as a Measure of “Healthy Aging”
An index that characterizes “healthy aging” should not
primarily reflect a single major disease process, but
should instead be sensitive to multiple forms of age-
related disease, and should indeed predict multiple age-
associated outcomes besides survival alone. The index
developed above was thus further evaluated along these
lines in order to judge its value as a comprehensive
measure of healthy aging. We first evaluated whether
the index was able to characterize multiple forms of
age-related disease, which appeared plausible, since
some variables included in the index (e.g., number of
step-ups completed and contrast sensitivity) had a simi-
lar association with mortality regardless of the assigned
cause of death (see Figure 4). We therefore hypothesized
that model output would be informative with respect to
sub-populations of subjects that appeared to develop dif-
ferent types of age-related pathology.
A risk score was assigned to each subject based upon
the 13-variable index, such that for each subject, the
assigned score was generated from an index in which
coefficients were estimated using data from all other
subjects (i.e., leave-one-out cross-validation). After
scores had been assigned in this fashion, subjects were
divided into two equally sized groups, based upon
whether assigned scores were above or below the cohort
median, and we evaluated the survivorship patterns of
the two groups (Figure 8). Initially, we applied this ana-
lysis to the entire cohort, and as expected, found that
subjects assigned low risk scores survived significantly
longer than those assigned high risk scores (Figure 8A;
P < 0.001; log-rank test). We then repeated the proce-
dure, but limited the analysis to subjects for which the
assigned cause of death was cancer (n = 426), cardiovas-
cular disease (n = 467), or other non-accidental causes
of death (n = 586). In each case, scores generated from
the 13-variable index led to subject groupings with sig-
nificantly different survival patterns (P < 0.021; log-rank
test) (Figures 8B - D). We next considered whether the
index primarily characterized deleterious health effects
of smoking or diabetes, given that these factors are asso-
ciated with multiple forms of age-related illness. This
did not appear to be the case, however, because as
above, we found that for self-identified past or current
smokers (n = 1776), self-identified non-smokers
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Figure 8 The 13-variable index distinguishes between short and long-lived subjects with respect to multiple sub-cohorts. The index
was used to assign a risk score to each subject using leave-one-out cross validation. In this method, a score is assigned to each of the
n subjects, based upon a model fit to data from the other n - 1 subjects included in the dataset. After a score had been assigned to all subjects,
the median score among all subjects was calculated. Subjects were assigned to a “low-risk group” if their score was below the median value,
and were assigned to a “high-risk group” if their score was above the median value. The solid red line corresponds to the estimated Kaplan-
Meier survival curve for the low-risk group, and the solid black line corresponds to the estimated curve for the high-risk group. Dotted red and
black lines represent 95% confidence limits. In part (A), survival curves were generated from all n = 4097 subjects. In parts (B) - (H), the analysis
was performed with respect to certain sub-populations of subjects. These sub-populations include (B) the n = 426 subjects dying of cancer,
(C) the n = 467 subjects with cardiovascular-related deaths, (D) the n = 586 subjects with non-accidental deaths unrelated to cancer or
cardiovascular disease, (E) the n = 1776 past or present smokers, (F) the n = 2316 non-smokers, (G) the n = 274 diabetic subjects, and (H) the
n = 3823 non-diabetic subjects. P-values were generated from a log-rank test of the null hypothesis that low and high-risk groups have identical
Kaplan-Meier survival curves [116].
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(n = 2316), subjects reporting that they had been told by
a doctor they were diabetic (n = 274) and apparent non-
diabetics (n = 3823), index-generated risk scores led to
subject groupings with significantly different survival
patterns (P < 0.001; log-rank test) (Figures 8E - H).
Taken together, these analyses confirmed that the index
characterizes mortality among subjects with multiple
assigned causes of death, and show that the index is not
primarily a reflection of a subject’s smoking or diabetes
status.
The value of the index as an indicator of multiple
forms of age-related illness was further evaluated using
a second analytical strategy. In particular, we evaluated
whether data patterns associated with subjects develop-
ing one type of pathology could be used to predict sur-
vivorship among subjects developing an entirely
different type of pathology. To apply such a test, we
focused on three groups of subjects, for which physi-
cian-adjudicated cause of death was cancer (n = 426),
cardiovascular disease (n = 467), or other non-acciden-
tal/non-cancer/non-cardiovascular disease (n = 586),
respectively. We estimated coefficients of the 13-variable
model using data from one group of subjects dying of
one specific cause (the training set), and then used these
coefficients to generate risk scores for another group of
subjects dying from a different cause (the test set) (Fig-
ure 9). Among the three groups of subjects, there were
six possible training-test set pairings, and in each case,
we evaluated whether risk scores generated in this fash-
ion led to concordance estimates larger than expected
by chance (Figure 9). In each of the six scenarios, we
found that risk scores led to significant concordance
estimates (P < 0.016). For example, when index coeffi-
cients were estimated using data from subjects appar-
ently dying of cancer, this index was applied to generate
risk scores for subjects that appeared to die of cardio-
vascular disease, and the concordance between risk
scores and survival times in this latter group was 0.562,
which is much larger than expected by chance (P =
0.002; see Figure 9). These results suggest that the mod-
el’s prognostic value arises from characterization of pro-
cesses more general than any one type of disease, and
support the hypothesis that the model provides a char-
acterization of healthy aging.
The index predicted mortality patterns, regardless of
the assigned cause of death, but only a fraction of the
4097 women included in our analysis died during the
period of follow-up (1523 of 4097; 37.2%). It was there-
fore of interest to determine whether risk scores gener-
ated from the index were related to long-term outcomes
among subjects that survived the follow-up period. For a
subset of the surviving subjects (923 ≤ n ≤ 1315), several
outcome measures had been evaluated at the ninth SOF
visit (occurring between 12/2006 and 7/2008; mean
follow-up time: 20 years), and we therefore could evalu-
ate whether these outcomes were associated with index-
generated risk scores. For each of the 4097 subjects, a
risk score was generated based upon an index with coef-
ficients estimated using data from all other subjects (i.e.,
leave-one-out cross-validation; see above), and these
scores were then standardized with respect to the base-
line cohort of 4097 women (i.e., mean = 0, std. dev. =
1). These standardized risk scores were, as expected,
lower on average among subjects that survived the fol-
low-up period (mean score: - 0.26 ± 0.016), relative to
those that died (0.46 ± 0.028). With respect to survivors,
however, risk scores were associated with cognitive out-
comes and measures of overall health (Figure 10). Lower
risk scores were, on average, characteristic of subjects
with higher scores on tests of cognitive function (Short-
mini-mental status exam and California Verbal learning
test; Figures 10A and 10B), subjects with lower scores
on measures of geriatric depression (Geriatric Depres-
sion Scale; Figure 10), and subjects that reported a smal-
ler number of prescription medications (Figure 10D).
Risk scores were also associated with physical perfor-
mance measures at the ninth SOF visit, as well as the
change in physical performance between the first and
ninth visits. For example, at the ninth visit, risk scores
were lower among subjects with higher grip strength
(Figure 10E), and between visits one and nine, the
decline in grip strength was larger on average among
subjects assigned higher risk scores (Figure 10F). A simi-
lar trend was present with respect to the number of
impairments associated with daily living (six-variable
index). Risk scores were lower among subjects that
reported fewer daily living impairments at the ninth visit
(Figure 10G), and were also lower among subjects for
which the reported number of daily living impairments
remained constant between the first and ninth visit (Fig-
ure 10H). These results demonstrate that, apart from
mortality patterns, the 13-variable index had a long-
term association with measures of cognitive function,
mental outlook, indicators of overall health status, and
measures of physical performance.
Discussion
The prospects of long-term survival and successful aging
can be evaluated in healthy adults based upon character-
istics that reflect an individual’s aging trajectory. In clin-
ical settings, these characteristics can identify those at
greatest risk of developing age-related disease, at a time
prior to disease onset, when preventative measures can
still be implemented effectively [3]. Moreover, for
research purposes, such characteristics provide useful
standards for the evaluation of human anti-aging inter-
ventions [4]. This study has identified individual factors
that are most strongly associated with long-term survival
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Figure 9 Cross-validation by cause of death. Index coefficients were estimated based upon a training set of subjects that had died from one
specific cause (cancer, cardiovascular, or non-cancer/non-cardiovascular). This generated a fitted model that was applied to a test set of subjects
that had died from another specific cause, which differed from that of subjects in the training set. The discrimination ability of the model with
respect to the survival times of subjects belonging to the test set was measured by estimating the concordance index (C). Train and test sets
were either the n = 426 subjects that died of cancer, the n = 467 with cardiovascular-related deaths, or the n = 586 subjects with non-
accidental deaths unrelated to cancer or cardiovascular disease. The dotted vertical line represents the estimated concordance index obtained
for each cross-validation scenario. The density shown corresponds to a null distribution generated by 10,000 simulation trials. In these
simulations, survival times in the training set were randomly permuted among subjects prior to estimation of model coefficients. The null
distribution thus provides an indication of concordance values likely to arise by chance.
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Figure 10 Risk scores generated from the 13-variable index are associated with multiple outcomes among subjects surviving the
follow-up period (mean follow-up time: 20 years). Risk scores were calculated from baseline measures for all 4097 subjects and standardized
to have a mean of zero and standard deviation of one. Outcome measures were available for n = 923 to 1296 subjects, and included (A) Mini-
mental status exam score (0 - 26 point scale; n = 98 - 257 per group), (B) California Verbal Learning Test (10 minute delay, free recall; 0 - 9 point
scale; n = 91 - 275 per group), (C) Geriatric depression score (0 - 15 point scale; n = 79 - 225 per group), (D) total number of prescription
medications listed by each subject (n = 111 - 336 per group), (E) average of right and left hand grip strength (kg) (n = 79 - 763 per group), (F)
change in average grip strength between the first and ninth visits (n = 79 - 389 per group), (G) reported number of impairments associated with
daily living (n = 84 - 359 per group) and (H) the difference in reported number of daily living impairments between the first and ninth visits (n =
41 - 357 per group). The p-value listed in each panel was generated from an F-test of between-group differences in mean risk score (i.e., one
way analysis of variance). Lowercase letters above each bar correspond to results from post hoc Tukey-Kramer comparisons, with significant
differences between groups that do not share the same letter (P < 0.05).
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within a healthy cohort of older women between 65 and
69 years of age. Surprisingly, visual contrast sensitivity
was among the top 5 strongest predictors of survival
relative to all 377 phenotypic measures evaluated in our
study (mean AUC = 0.570) (Table 1). This measure may
warrant increased attention in clinical evaluation, since
our findings indicate that its prognostic significance is
comparable to that of smoking and diabetes status. Our
study has also derived an evidence-based index that ties
together multiple dimensions of an aging adult (mean
AUC = 0.673). This index is based upon the number of
step-ups completed in 10 seconds, contrast sensitivity,
blood pressure, pulse and several pieces of information
easily obtained from a questionnaire or brief interview
(Table 2). The prognostic capacity of this index did not
appear to depend upon characterization of any one dis-
ease process, and among surviving subjects, scores gen-
erated from the index were associated with multiple
long-term outcomes (e.g., mini-mental status exam
score). These properties require further validation in
independent cohorts, but suggest that the index could
provide a marker of healthy aging patterns in older
women (65-69 years of age), and that age-sensitive com-
ponents of this index should be considered for possible
use as endpoints for research centered on anti-aging
interventions in humans.
The analytic approach used in our study differs in two
main ways from previous investigations of data gener-
ated from the study of osteoporotic fractures (SOF).
First, we have focused on the youngest subjects that
enrolled in the study (i.e., ages 65 - 69 at baseline),
while prior investigations have based their analyses on
the complete SOF cohort (ages 65 - 89 at baseline). We
have chosen to consider only younger subjects, since in
these individuals, the burden of age-related disease was
reduced at the time of baseline examination. This was
desirable, since we expected that those already affected
by age-related disease would exhibit a distinct signature
set of phenotypic characteristics (i.e., a “frail” phe-
noytpe), and that this signal in the data would interfere
with our ability to identify patterns associated with
long-term survival, which we expected to be more infor-
mative in terms of aging mechanisms [25]. Secondly,
prior investigations have aimed to identify single factors
associated with survival, and to determine which factors
were independent predictors of survival after adjusting
for other influential variables. Along these lines, pre-
vious analyses have identified many variables associated
with all-cause mortality in the SOF cohort, including
fracture incidence and rate of bone loss [63-68], markers
of cardiovascular health and function [69,70], biochem-
ical measures [71-74], body composition traits [30,75],
physical activity [76], sleeping habits [77], depressive
symptoms [48], marital status and social connectedness
[49], as well as visual acuity and contrast sensitivity [38].
In our investigation, we also identified statistically signif-
icant predictors of survival, which remained significant
after adjustment for other variables. However, our
approach was more stringent in some respects, since we
aimed to identify variables that were both significantly
related to survival and also the strongest predictors rela-
tive to other baseline variables evaluated in the SOF
cohort. These variables were isolated by adopting a glo-
bal data mining strategy that involved competition
among a wide range of variables, and variable combina-
tions, allowing the most useful variables to emerge in a
data-driven fashion.
Visual contrast sensitivity was a strong independent
predictor of survival as well as an influential component
of the multivariate index we derived. This result is con-
sistent with conclusions from a previous study of SOF
data, which found that among all SOF participants (65
to 89 years of age), contrast sensitivity (and visual
acuity) were significantly associated with mortality [38].
Previous analyses have also identified poor contrast sen-
sitivity as a risk-factor for deleterious aging outcomes,
such Alzheimer’s disease [78] and hip fracture [79]. It is
unlikely that the prognostic value of contrast sensitivity
in our analysis is due to an association between contrast
sensitivity and accidental death (e.g., car accidents),
since in our analysis, cases of accidental death were
treated as right-censored data. Our findings therefore
complement those that have accumulated from studies
of other populations, which have documented associa-
tions between all-cause mortality and indicators of visual
status, such as lens changes [80], poor visual acuity [81],
self-reported visual impairment [82], cataract or prior
cataract removal [83], age-related macular degeneration
[84], retinopathy [85], nuclear sclerotic cataract severity
[86] and high intraocular pressure [87]. Many of these
associations have been present in both diabetic and
non-diabetic populations [85], and it has been specu-
lated that measures of visual function could serve as
indicators of biological aging [81,82,84,88]. Contrast sen-
sitivity has proven to be an especially sensitive measure
of visual function that correlates with real-world perfor-
mance on vision-oriented tasks (e.g., driving, reading
speed, face recognition) [89-91]. It is known that con-
trast sensitivity declines with age, although the func-
tional basis of this decline is unclear and may involve
multiple factors [92]. To some degree, age-related con-
trast sensitivity decline could reflect choroidal neovascu-
larization that can accompany development of age-
related macular degeneration (AMD) in some older indi-
viduals, given that contrast sensitivity scores are lower in
AMD patients [93], and that therapies inhibiting choroi-
dal neovascularization in AMD patients improves con-
trast sensitivity [94]. On the other hand, contrast
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sensitivity is also impaired by several other ocular dis-
eases (e.g. cataract, glaucoma, diabetic retinopathy)
[95-97], suggesting that multiple mechanisms contribute
to diminished contrast sensitivity with age. It is interest-
ing to note that contrast sensitivity may represent a gen-
eral indicator of a subject’s sensory perception, and that
useful prognostic data might have been obtained from
other sensory systems not evaluated during baseline
exams (e.g., hearing test). For instance, among men and
white women, one study found that associations
between vision and hearing impairment with survival
were additive, with concurrent vision and hearing loss
more strongly associated with mortality than impair-
ment of either sensory system individually [82].
Our results provide a validated index of traits, which
predicts survival regardless of the assigned cause of
death, and is significantly associated with several other
long-term outcomes in addition to survival per se. The
principle that underlies our index is that favorable com-
binations of measurements can be identified using a
data mining approach, which aims to identify a set of
non-redundant variables that predict long-term survival
within a cohort for which age-related disease burden is
low. The model we have generated by this approach
includes many variables known to predict survival and
several might have been surmised in advance (e.g.,
smoking and diabetes status). However, the exact com-
bination of 13-variables (out of 4.05 × 1023 possible 13
variable combinations) is less likely to have been sur-
mised in advance of our study, and likewise, the ranking
of variables according to importance as listed in Table 2
was not obvious at the outset. For the purpose of char-
acterizing frailty, previous work has developed a 5-vari-
able “frailty index” [16]. By analogy, our work suggests
that a multi-variable index of “healthy aging” might be
based upon variables drawn from at least six domains of
the aging adult, including (i) a measure of physical func-
tion, (ii) smoking status/history, (iii) diabetes status/his-
tory, (iv) self-rated health, (v) visual performance and
(vi) an indicator of cardiovascular health. The 13-vari-
able index we identified includes specific measures that
fall into each of these categories, but we note that sub-
stitute variables can be used in some cases with little
overall effect on predictive performance. For example, as
a measure of physical function, our index suggests that
the number of step-ups completed by a subject in 10 sec-
onds was the most informative variable, but concor-
dance estimates of the index decreased only slightly
when walking speed or grip strength was substituted for
this variable (Table 2). The multivariate index we devel-
oped, therefore, should not be interpreted in overly rigid
terms, but should be viewed as indicative of certain
classes of measurements that are likely to be informative
when used in combination, with the precise choice of
measurements dictated primarily by practicality of clini-
cal evaluation.
There are both advantages and disadvantages of the
methodology we have used to derive an index that pre-
dicts long-term survival and which appears to character-
ize “healthy aging”. The main advantage of our
approach is that it is data-driven and variables were
chosen in an objective fashion using a cross-validation
criterion that ensures generalization ability (at least with
respect to the SOF cohort we studied). The index we
have developed is thus validated in terms of its ability to
predict long-term survival patterns, and as we have
shown, it also predicts outcomes among survivors that
are unrelated to mortality (see Figure 10). A disadvan-
tage of our approach is that, while an index built using
data-mining methods may perform well in terms of pre-
dictive ability, this does not guarantee that the index
will be easy to implement in practice, and it also does
not guarantee that index components will fit into a con-
ceptual scheme useful for understanding what “healthy
aging” means. To develop a rule-based scheme for char-
acterization of “frailty”, for instance, Fried et al. [16] first
developed a conceptual framework, devised a rule-based
system within this framework, and then validated the
predictive validity of the rule-based system using survi-
val data from the Cardiovascular Health Study. The con-
cept-driven approach followed by Fried et al. [16] thus
ensures that the index generated can be connected to a
broader framework and that the index is sensible from a
medical standpoint. None of these assurances can be
claimed of the data mining methodology we have imple-
mented in this study. However, it can be argued that an
index that fits an elegant theory but is sub-optimal in
terms of predictive capacity is, with good reason, less
likely to be assigned preference in practical contexts.
Moreover, an appealing aspect of data-driven indices is
that they provide a suitable and well-supported founda-
tion for building new conceptual schemes. Indeed, the
index developed by our analysis is sensible in many
respects, given that physical performance measures are
frequently advanced as cumulative indicators of general
health [33,39,98-102], that smoking has been viewed as
accelerating many features of aging [103-105], that dia-
betes is known to re-enforce age-related declines in telo-
mere length and peripheral blood flow [106-108], that
visual indices have been viewed as suitable for measure-
ment of biological age [81,82,84,88], and that the chron-
ological age of subjects was in fact selected as the fourth
most-important component of our index (a reassuring
“positive control” for our methodology).
We anticipate that, in several ways, further studies will
improve and refine the index we have developed here.
Our analysis evaluated a wide range of variables that
relate to multiple aspects of an aging adult, including
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past medical history and measures that reflect health
status at presentation. It is quite possible, however, that
other variables, not represented in our analysis, might
have been better predictors of survivorship than those
available in the SOF dataset. For example, our investiga-
tion did not include biochemical measurements, such as
indicators of systemic inflammation [73], or markers
based upon gene expression in blood cells [109], or gen-
otype information derived from single nucleotide poly-
morphisms [110]. It would be valuable to determine
how such measures compete with those identified in
our analysis, and whether any of these measures would
contribute useful information to the index that we have
developed. A second avenue for improvement is further
validation of our index as a measure of healthy aging
that reflects multiple forms of age-related illness. The
index we developed was able to discriminate survival
times among subsets of subjects for which the assigned
cause of death was cancer, cardiovascular disease or
non-cancer/non-cardiovascular disease. It is likely, how-
ever, that there exists some degree of overlap among
these categories, which is not reflected in available SOF
data, as well as some variance in the degree of certainty
associated with the assigned cause of death. We there-
fore anticipate that analytical methods used in our ana-
lysis can be profitably applied in other contexts, possibly
with narrowed and more fine-scaled cause of death cate-
gorizations, which would serve to further evaluate the
index as a measure of an individual’s aging trajectory
that is sensitive to multiple disease processes. Lastly, the
index we have generated has been validated primarily
among community-dwelling Caucasian women between
the ages of 65 and 69. We have evaluated the perfor-
mance of this index with respect to older subjects from
the SOF cohort (i.e., ages 70-89; see Additional File 4),
and have found that its prognostic value declines with
age, suggesting that certain indicators of long-term sur-
vival in younger populations (e.g., smoking and diabetes
status) may not provide ideal tools for predicting com-
paratively short-term outcomes in older cohorts. We
therefore expect that the index we developed will be
most useful when applied to subjects that fall within a
specific age bracket (i.e., 65-69 years of age, approxi-
mately). Moreover, with respect to subjects of this age,
further validation of the index is necessary to determine
whether findings from this study generalize to other
independent cohorts, particularly cohorts that include
subjects of both genders and a broad range of ethnic
backgrounds and environmental settings. The most use-
ful index to clinicians, as well as to research investiga-
tors, will most likely consist of variables that
consistently emerge as the strongest predictors in multi-
ple epidemiological datasets that include a comprehen-
sive range of measures.
The translation of findings from basic aging research to
practical anti-aging interventions would benefit greatly
from the identification of variables that best predict
future health outcomes in rodent models and people.
Direct tests of putative anti-aging interventions for effects
on survival in human populations would be extremely,
perhaps prohibitively, expensive. In contrast, surrogate
endpoints that are robustly associated with both long-
term survival and exceptionally good health might be
used in research trials to infer whether an intervention
has favorably altered the odds of long-term survival.
Some of the variables highlighted in our analysis exhibit
increasing or decreasing trends across age groups, and
likewise, risk scores generated from the index we devel-
oped change monotonically with age (see Additional File
2). We therefore propose that certain age-sensitive vari-
ables identified in our study be considered for inclusion
within a panel of “validation measures”, that once devel-
oped, could serve as a standard set of traits to be evalu-
ated in human studies of anti-aging interventions. So far,
clinical studies of anti-aging interventions, such as caloric
restriction without malnutrition [23], have not evaluated
measures of physical performance, contrast sensitivity, or
most other variables included in the index we have devel-
oped. Ultimately, however, we believe that the determina-
tion of whether an intervention alters the rate of aging in
humans (or other species) should not be based upon idio-
syncratic sets of measures chosen by particular research
groups, but rather, upon validated sets of measures that
have emerged from independent global analyses of large
datasets, which are in this fashion shown to be dominant
predictors of long-term health and survivorship out-
comes. An additional benefit from the identification of
variables robustly associated with long-term human sur-
vival is the potential that, by “reverse translation”, such
variables will suggest new endpoints for evaluation in
basic aging research using model organisms [111,112].
Indeed, there are already several examples in which ana-
logues of human physical performance traits have been
successfully modeled in mice, worms and flies [113-115].
We anticipate that further development and characteriza-
tion of a robust healthy aging phenotype in humans,
based upon global analyses of comprehensive datasets,
will promote further work along these lines and enhance
the synergy between basic and applied aging research.
Conclusions
The recognition of healthy aging patterns and prediction
of long-term survival is an important problem in clinical
contexts with implications for the design of intervention
studies that aim to evaluate anti-aging treatments. This
investigation has focused on the challenging task of pre-
dicting long-term (20-year) survival within a healthy
cohort of 4,097 women (ages 65 - 69) enrolled in the
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Study of Osteoporotic Fractures (SOF). Surprisingly,
among 377 predictor variables evaluated, contrast sensi-
tivity scores were among the strongest predictors of sur-
vival (ranked 5th of 377 variables, mean AUC = 0.570).
We have implemented a data mining approach to
develop a multivariate index that predicts mortality pat-
terns among all 4,097 subjects (mean AUC = 0.673), as
well as within sub-cohorts for which the assigned cause
of death was cancer, cardiovascular disease, or non-can-
cer/non-cardiovascular disease. Among subjects that
survived an average follow-up time of 20 years, this
index was associated with multiple outcomes, including
tests of cognitive function, geriatric depression, number
of daily living impairments and grip strength. The index
we present requires further validation with respect to
other cohorts. However, our results suggest that compo-
nents of our index characterize the clinical presentation
of “healthy aging” as it frequently occurs in older
women between 65 and 69 years of age. We suggest
that our data-guided approach to index development
can be profitably applied to other comprehensive data-
sets to further develop standardized criteria for recog-
nizing healthy aging in older adults.
Additional material
Additional file 1: Overview of SOF Cohort Evaluated in this Study.
This file provides a flow chart diagram describing the filtering of the
9704 subjects within the SOF database (ages 65 - 89), along with an
overview of assigned causes of death among the 4097 subjects (ages 65
- 69) included in our analyses.
Additional file 2: List of 377 Variables Included in Analysis. This file
provides a list of the 377 variables evaluated in the analysis. For each
variable, hazard ratio estimates are provided along with 95% confidence
intervals and associated p-values. Hazard ratios are estimated within
univariate Cox regression models and also within models that have been
adjusted for subject age, smoking and diabetes status. A separate list of
88 variables excluded from the analysis due to > 5% missing values is
also provided.
Additional file 3: Cross-Sectional Association of Index Components
with Subject Age. This file provides analyses of relationships between
selected index components and subject age, as well as the relationship
between index-generated risk scores and subject age.
Additional file 4: Evaluation of index performance with respect to
older subjects from the SOF cohort (70 - 89 years of age). The 13-
variable index we present (Table 2) was developed based upon survival
patterns among the youngest subjects of the SOF cohort (i.e., ages 65 -
69). It was of interest, however, to evaluate the prognostic value of the
index with respect to older SOF subjects (i.e., ages 70 - 89), since this
would provide further validation of our index based upon an
independent cohort. Additionally, this analysis was expected to provide
some insight into the prognostic value of the index among older SOF
subjects (ages 70-89) relative to the younger SOF subjects (ages 65-69)
that were the main focus of our investigation. This file therefore provides
a cross-validation evaluation of the 13-variable model with respect to
SOF subjects aged 70-74 (n = 3033), 75-79 (n = 1538), 80-84 (n = 765)
and 85-89 (n = 228). Performance with respect to each age group was
evaluated using 10,000 cross-validation trials, with correspondence
between observed and predicted survival patterns assessed using the
concordance metric (C) described in the Methods section and applied
elsewhere in this paper.
Additional file 5: Random Variable Selection as a Modeling
Strategy. Previous investigations have suggested that exact specification
of variables is not always an important factor determining the
performance of a prognostic model. This file therefore contains analyses
that compare prognostic performance of the 13-variable model
generated in our study (see Table 2) with the performance of 13-variable
models that include variables chosen at random from a pool of variables
(either with or without pre-filtering of the variable pool). We note that
sensitivity of model performance to variable specification is expected to
increase for models that are based upon a smaller number of predictor
variables.
Additional file 6: Comparison of model performance to an index
that quantifies the accumulation of deficits or health problems.
Previous studies have shown that high-quality predictive models can be
generated based upon an index that appropriately reflects the
accumulation of health problems or “deficits”. Such deficits should
exhibit greater frequency with age, be indicative of health status, but
should not be universally present among older subjects. Examples of
such deficits include the presence of depression, weight loss, difficulty
with daily living tasks and a history of heart disease. This file generates
an “SOF Deficit Index” and compares the performance of this index to
that of the 13-variable healthy aging index presented in Table 2. The
comparison is made with respect to the young SOF subjects that are the
main focus of this paper and also with respect to older SOF cohorts
aged 70-74 (n = 3033), 75-79 (n = 1538), 80-84 (n = 765) and 85-89 (n =
228).
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